These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39033992)

  • 1. METTL14-mediated N6-methyladenosine modification of TCP1 mRNA promotes acute myeloid leukemia progression.
    Zhang M; Xie Z; Tan Y; Wu Y; Wang M; Zhang P; Yuan Y; Li J
    Cell Signal; 2024 Oct; 122():111304. PubMed ID: 39033992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification.
    Chen Z; Li Q; Li Z; Hu G
    Clin Exp Pharmacol Physiol; 2024 Nov; 51(11):e13924. PubMed ID: 39322401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCP1 increases drug resistance in acute myeloid leukemia by suppressing autophagy via activating AKT/mTOR signaling.
    Chen X; Chen X; Huang Y; Lin J; Wu Y; Chen Y
    Cell Death Dis; 2021 Nov; 12(11):1058. PubMed ID: 34750375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.
    Li J; Wu Y; Wang M; Chen X; Li Z; Bai X; Wu H
    Comput Math Methods Med; 2022; 2022():5787808. PubMed ID: 36118827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.
    Xu D; Han S; Yue X; Xu X; Huang T
    Mol Biotechnol; 2024 Aug; 66(8):2095-2105. PubMed ID: 37592151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL14 contributes to the progression of nasopharyngeal carcinoma through regulating the stability of AOC1 mRNA.
    Hu C; Song S; Zhao S; Xue Z; Zhu X
    Hereditas; 2024 Jul; 161(1):20. PubMed ID: 38956710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14-Mediated m6A Modification of
    Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.
    Li J; Li Z; Bai X; Chen X; Wang M; Wu Y; Wu H
    J Oncol; 2022; 2022():2756986. PubMed ID: 35178087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
    Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
    Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m
    Li L; Tang Q; Ge J; Wang D; Mo Y; Zhang Y; Wang Y; Xiong F; Yan Q; Liao Q; Guo C; Wang F; Zhou M; Xiang B; Zeng Z; Shi L; Chen P; Xiong W
    Clin Transl Med; 2024 Jul; 14(7):e1766. PubMed ID: 39021049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
    Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
    Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
    Zhang L; Luo X; Qiao S
    Br J Cancer; 2022 Jul; 127(1):30-42. PubMed ID: 35249103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
    Wen D; Xiao H; Gao Y; Zeng H; Deng J
    Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of METTL14 mediates the elevation of PERP mRNA N
    Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
    Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.